Sugi Predict

Sugi Predict / Compounds / SCHEMBL207829

SCHEMBL207829

SCHEMBL207829

Oc1ccccc1-c1c[nH]nn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 4/20 0.47
▸ SMARCA2 P51531 3/20 0.42
▸ SMARCA4 P51532 3/20 0.42
▸ PBRM1 Q86U86 3/20 0.42
▸ NR1I2 O75469 2/20 0.42
▸ BRD4 O60885 1/20 0.42
▸ ALOX15 P16050 6/20 0.41
▸ HSD17B10 Q99714 4/20 0.41
▸ MAPK1 P28482 2/20 0.41
▸ TP53 P04637 1/20 0.41
▸ SMN1; SMN2 Q16637 6/20 0.40
▸ HPGD P15428 4/20 0.40
▸ MAPT P10636 4/20 0.40
▸ MEN1 O00255 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ NFKB1 P19838 2/20 0.40
▸ NFKB2 Q00653 2/20 0.40
▸ RELA Q04206 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30549532 1.00 IDO1 (0.47) IDO1SMARCA2SMARCA4PBRM1NR1I2
Hydrochloric Acid SCHEMBL30549508 0.98 IDO1 (0.46) IDO1SMARCA2SMARCA4PBRM1NR1I2
SCHEMBL1042068 0.94 IDO1 (0.42) IDO1SMARCA2SMARCA4PBRM1NR1I2
SCHEMBL2197897 0.85 ALDH1A1 (0.38) IDO1PBRM1ALOX15MAPK1TP53
SCHEMBL472926 0.85 ALDH1A1 (0.39) IDO1ALOX15HSD17B10MAPK1TP53
SCHEMBL28117640 0.82 TRPA1 (0.39) IDO1ALOX15HSD17B10MAPK1TP53
SCHEMBL5613032 0.82 MEN1 (0.32) IDO1MEN1KMT2A
Hydrochloric Acid SCHEMBL21412101 0.82 MAOA (0.37) IDO1ALOX15HSD17B10MAPK1TP53
SCHEMBL304360 0.80 HPGD (0.48) IDO1ALOX15HSD17B10TP53SMN1; SMN2
SCHEMBL29569413 0.79 ERN1 (0.34) MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113527937-A Water-based organic nano ink applied to organic thin film device and preparation method thereof 深创高新产业研究中心(深圳)有限公司 2021-10-22 — — CN claimed
EP-3773552-A1 COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE PTC Therapeutics, Inc. (US) 2021-02-17 — — EP claimed
CN-112318907-A Preparation method of levofloxacin and sodium chloride injection high-barrier soft bag 湖北多瑞药业有限公司 2021-02-05 — — CN claimed
WO-2019191229-A1 COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE PTC THERAPEUTICS, INC. (US) 2019-10-03 — — WO claimed
US-20050143578-A1 Compounds and methods SMITHKLINE BEECHAM CORPORATION 2005-06-30 — — US claimed
EP-1434772-A4 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORP (US) 2005-05-04 — — EP claimed
US-20040192914-A1 Compounds and methods SMITHKLINE BEECHAM CORPORATION 2004-09-30 — — US claimed
EP-1434772-A1 COMPOUNDS AND METHODS SmithKline Beecham Corporation (US) 2004-07-07 — — EP claimed
WO-2003031434-A1 COMPOUNDS AND METHODS SMITH KLINE BEECHAM CORPORATION (US) 2003-04-17 — — WO claimed
US-5955005-A ULTRAVIOLET ABSORBERS FOR TEXTILES USING BENZOPHENONE ALCOHOLS CLARIANT FINANCE (BVI) LIMITED (VG) 1999-09-21 — — US claimed
EP-0011719-B1 6-(2-HYDROXY-4-(1,2,3-TRIAZOLYL-(2))-PHENYL)-2,4-DIOXO-1,3,5-TRIMETHYL-HEXAHYDRO-S-TRIAZINES, AND THEIR PREPARATION AND USE AS INTERMEDIATES IN THE SYNTHESIS OF OPTICAL BLEACHING AGENTS BAYER AG (DE) 1981-09-30 — — EP claimed
US-4263435-A 6-[2-Hydroxy-4-(1,2,3-triazol-2-yl)-phenyl]-2,4-dioxo-1,3,5-trimethyl-hexahydro-s-triazines and their preparation BAYER AKTIENGESELLSCHAFT (DE) 1981-04-21 — — US claimed
CN-120129875-A Photosensitive resin composition, method for producing cured relief pattern, and semiconductor device 旭化成株式会社 2025-06-10 — — CN disclosed
CN-112368641-B Photosensitive resin composition, photosensitive sheet, cured film thereof, method for producing cured film, and electronic component 东丽株式会社 2025-05-02 — — CN disclosed
CN-118946956-A Composition for forming polymer film and method for forming selective polymer film 日产化学株式会社 2024-11-12 — — CN disclosed
CN-118938601-A Negative photosensitive resin composition and method for producing cured relief pattern 旭化成株式会社 2024-11-12 — — CN disclosed
EP-0002677-B1 GLUCOSAMINE-PEPTIDE DERIVATIVES AND THEIR PHARMACEUTICAL COMPOSITIONS Takeda Chemical Industries, Ltd. (JP) 1982-10-13 — — EP disclosed
EP-0040357-A1 Process for the preparation of v-triazolyl-(2) phenols BAYER AG (DE) 1981-11-25 — — EP disclosed
EP-0011719-B1 6-(2-HYDROXY-4-(1,2,3-TRIAZOLYL-(2))-PHENYL)-2,4-DIOXO-1,3,5-TRIMETHYL-HEXAHYDRO-S-TRIAZINES, AND THEIR PREPARATION AND USE AS INTERMEDIATES IN THE SYNTHESIS OF OPTICAL BLEACHING AGENTS BAYER AG (DE) 1981-09-30 — — EP disclosed
EP-0011719-A1 6-(2-Hydroxy-4-(1,2,3-triazolyl-(2))-phenyl)-2,4-dioxo-1,3,5-trimethyl-hexahydro-s-triazines, and their preparation and use as intermediates in the synthesis of optical bleaching agents BAYER AG (DE) 1980-06-11 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040192914-A1 Compounds and methods METAP2, METAP1, DNPEP IDO1 300/4885SMARCA2 3666/4885SMARCA4 3709/4885
US-20050143578-A1 Compounds and methods METAP2, METAP1, DNPEP IDO1 316/4885SMARCA2 3614/4885SMARCA4 3832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.